Macular Degeneration: Steps to Protect Your Vision
Understanding Macular Degeneration
AMD affects the macula, the small central area of the retina responsible for sharp, detailed vision. Understanding how the disease develops is the first step in protecting your sight and knowing when to seek care.
The retina is the light-sensitive tissue lining the back of the eye, and the macula sits at its center. The macula allows you to see fine details clearly, which means it is essential for reading, driving, and recognizing faces. When AMD damages the macula, central vision becomes blurry, distorted, or missing, while side (peripheral) vision typically remains intact.
Dry AMD is the most common form of the disease and develops slowly over years. In the early stages, small yellowish deposits called drusen form beneath the retina. As drusen accumulate and grow larger, they can damage retinal cells.
In the advanced stage of dry AMD, called geographic atrophy (GA), areas of retinal cells die off completely. This can cause significant central vision loss over time.
Wet AMD, also called neovascular AMD, occurs when abnormal blood vessels grow beneath the macula. These fragile vessels leak blood and fluid, damaging the retina rapidly. The body uses a protein called vascular endothelial growth factor (VEGF) to grow these abnormal vessels. Wet AMD is less common than dry AMD, but it can cause rapid and severe central vision loss if not treated promptly.
Who Is at Risk for AMD?
Certain factors make some people more likely to develop AMD than others. Knowing your personal risk can help you make informed decisions about screening and prevention.
The strongest risk factor for AMD is age. Risk increases substantially after age 50 and continues to rise with each decade. Family history also plays a major role. If a parent or sibling has AMD, your own risk is meaningfully higher. Researchers have identified several genes linked to the disease, confirming that heredity is a significant contributing factor.
Cigarette smoking is the most important modifiable risk factor for advanced AMD. Smoking damages blood vessels throughout the body, including the delicate vessels in the retina, and reduces protective antioxidant levels in the eye. Quitting smoking is the single most impactful step a person can take to lower their AMD risk, and former smokers continue to benefit even after stopping.
Several additional factors can increase the likelihood of developing AMD. Being aware of these can help guide conversations with your eye care provider.
- Being female, as women develop AMD at slightly higher rates
- Being of Caucasian or northern European descent
- Having high blood pressure or cardiovascular disease
- Eating a diet low in fruits, vegetables, and key nutrients
- Prolonged exposure to sunlight without eye protection
Prevention: Evidence-Based Steps
While age and genetics cannot be changed, there are meaningful steps you can take to reduce your risk of developing AMD or slowing its progression. These strategies are supported by research and recommended by leading eye health organizations.
Quitting smoking is the most effective preventive action you can take. Current smokers face a significantly higher risk of progressing to advanced AMD compared to nonsmokers. If you smoke, speak with your primary care provider about cessation programs and support resources. Even former smokers benefit, as risk decreases over time after stopping.
Certain nutrients help protect the macula from damage. Higher dietary intake of lutein, zeaxanthin, omega-3 fatty acids, and zinc has been associated with a reduced risk of early AMD. Focusing on whole foods that deliver these nutrients naturally is a practical and sustainable approach.
- Dark leafy greens such as spinach, kale, and collard greens (rich in lutein and zeaxanthin)
- Cold-water fish such as salmon, tuna, and sardines (rich in omega-3 fatty acids)
- Colorful fruits and vegetables including oranges, peppers, and berries (rich in antioxidants)
- Nuts, beans, and whole grains (sources of zinc and vitamin E)
The Age-Related Eye Disease Studies (AREDS and AREDS2), conducted by the National Eye Institute, found that a specific supplement formula can help prevent intermediate dry AMD from progressing to advanced forms. The AREDS2 formula includes vitamin C, vitamin E, lutein, zeaxanthin, zinc, and copper.
These supplements are not intended for everyone. They are recommended specifically for people who already have intermediate AMD or advanced AMD in one eye. A retina specialist can determine your AMD stage and advise whether AREDS2 supplements are right for your situation.
Prolonged sun exposure may contribute to retinal damage over time. Wearing sunglasses that block both UVA and UVB rays, along with a wide-brimmed hat when outdoors, are simple, practical measures. Choose sunglasses labeled with full UV protection.
High blood pressure and cardiovascular disease have been linked to AMD progression. The blood vessels in your retina respond to the same conditions that affect your heart and circulatory system. Maintaining a healthy weight, exercising regularly, and working with your doctor to manage blood pressure and cholesterol may help support your overall eye health.
Early Detection and Monitoring
AMD can be present for years without causing noticeable symptoms. Catching it early gives our specialists the best opportunity to monitor and manage the disease before significant vision loss occurs.
In its early stages, AMD often causes no symptoms at all. By the time vision changes become noticeable, the disease may have already progressed significantly. Routine dilated eye exams allow a retina specialist to detect early signs of AMD and begin monitoring before central vision is affected. Research confirms that early detection and prompt treatment of active wet AMD improve visual outcomes.
The Amsler grid is a simple tool you can use between office visits to monitor your central vision. It resembles a sheet of graph paper with a dot in the center. By covering one eye and focusing on the center dot, you can check for wavy, distorted, or missing areas in the grid lines.
If you notice new distortion or blank spots, contact a retina specialist promptly. Testing each eye separately and keeping a log of any changes helps you communicate clearly with your care team at follow-up visits.
A retina specialist uses several diagnostic tools to detect and monitor AMD. A dilated eye exam allows the doctor to view the retina directly. Optical coherence tomography (OCT) creates detailed cross-sectional images of the retina to identify fluid, drusen, and areas of thinning. Fluorescein angiography, which uses a dye injected into the bloodstream to photograph retinal blood vessels, can reveal leaking vessels associated with wet AMD. These tests guide treatment decisions and help track how the disease is changing over time.
Treatment Options for AMD
AMD treatment depends on the type and stage of the disease. Our retina specialists, Dr. Gaurav Gupta and Dr. Pranjal Thakuria, use the most current, evidence-based therapies to help preserve your vision and slow disease progression.
There is currently no proven medical treatment for early-stage dry AMD. At this stage, the focus is on monitoring, lifestyle modifications, and routine follow-up with a retina specialist. Quitting smoking, eating a nutrient-rich diet, protecting your eyes from UV light, and scheduling regular exams are the primary recommended strategies to keep the disease from advancing.
For people with intermediate dry AMD, or those with advanced AMD in one eye, the AREDS2 supplement formula is the only proven nutritional intervention shown to help slow progression to the advanced stage. A retina specialist can determine your AMD stage and advise whether these supplements are appropriate for you. Taking them without a confirmed intermediate or advanced diagnosis is not recommended.
Geographic atrophy (GA) is the advanced form of dry AMD. Two complement inhibitors are now FDA-approved to slow the growth of GA lesions. Syfovre (pegcetacoplan) and Izervay (avacincaptad pegol) are both delivered as intravitreal injections (injections directly into the eye) and are indicated specifically for geographic atrophy, not wet AMD.
Clinical studies have shown that these medications can slow GA progression over time. Both require ongoing injections, and a retina specialist will determine whether either option is appropriate based on your individual situation.
Intravitreal anti-VEGF injections are the most effective first-line treatment for wet AMD. These medications block the VEGF protein that drives abnormal blood vessel growth and leakage in the retina. Several options are currently available, and the choice of medication depends on your specific condition and treatment response.
- Eylea (aflibercept): typically given every 4 to 8 weeks after an initial loading phase
- Eylea HD (high-dose aflibercept): FDA-approved with extended dosing intervals of 8 to 16 weeks after initial loading doses
- Lucentis (ranibizumab): given approximately every 4 weeks
- Vabysmo (faricimab): a bispecific antibody targeting both VEGF and angiopoietin-2, with dosing intervals of 4 to 16 weeks
- Avastin (bevacizumab): FDA-approved for cancer and widely used off-label for eye conditions, given every 4 to 6 weeks
- Beovu (brolucizumab): given every 8 to 12 weeks, though it carries a risk of retinal vasculitis (inflammation of retinal blood vessels)
A retina specialist will select the most appropriate medication and dosing schedule for your condition.
Research into AMD treatments continues to advance. In 2024, the FDA authorized the Valeda Light Delivery System for multiwavelength photobiomodulation treatment of non-neovascular (dry) AMD. Early-stage research on AVD-104, a dual inhibition treatment, has shown promise in reducing retinal pigment epithelium loss after a single dose. Gene therapies and longer-lasting drug delivery systems are also under active investigation. A retina specialist can discuss which available or emerging options may be relevant to your stage of disease.
What to Expect During Treatment
If you are beginning anti-VEGF or complement inhibitor therapy, it helps to understand what the process involves so you can feel confident and prepared. Our team is here to guide you through every step.
Intravitreal injections are performed in a retina specialist's office. The eye is numbed with anesthetic drops and cleaned with an antiseptic solution before the injection. The injection itself takes only seconds. Most patients describe feeling pressure or mild discomfort rather than sharp pain.
After the injection, some temporary blurriness, mild redness, or a sensation of something in the eye is common. These effects typically resolve within a day or two. If you experience significant pain, worsening vision, or increasing redness after an injection, contact our office promptly.
Both anti-VEGF injections for wet AMD and complement inhibitor injections for geographic atrophy require ongoing treatment and regular monitoring. Your retina specialist will establish a schedule based on how your eye responds. Some newer medications allow longer intervals between injections. Regular OCT scans and eye exams guide decisions about extending or shortening treatment intervals to achieve the best possible outcome for your vision.
Living With Macular Degeneration
A diagnosis of AMD can feel overwhelming, but many people with the condition continue to live full, active lives. There are practical tools, community resources, and strategies that can make a meaningful difference in daily life.
Low-vision aids such as magnifying glasses, large-print books, and screen readers can help with reading and everyday tasks. Increasing lighting at home, using high-contrast labels, and adjusting computer display settings are useful adaptations. An occupational therapist or low-vision specialist can recommend tools and techniques tailored to your specific needs.
It is natural to feel anxious or frustrated when vision changes begin to affect independence. Connecting with support groups, whether in person or online, can provide encouragement from others who share similar experiences. Organizations such as the BrightFocus Foundation and the American Macular Degeneration Foundation offer educational resources and community connections that many patients find helpful.
Checking your vision regularly with the Amsler grid, testing each eye separately, is one of the most important things you can do between appointments. Track any new symptoms such as increased distortion, blurriness, or dark spots in your central vision. Keeping a simple log of changes helps your retina specialist understand how your condition is evolving and adjust your care plan accordingly.
When to See a Retina Specialist
Knowing when to schedule a routine exam and when to seek urgent care is essential for protecting your vision with AMD.
If you are 50 or older, schedule a comprehensive dilated eye exam regularly, even if your vision seems fine. If you have a family history of AMD, a smoking history, or other known risk factors, earlier and more frequent screening may be appropriate. An optometrist or general ophthalmologist can perform initial screening and refer you to a retina specialist if any signs of AMD are detected.
Some symptoms require immediate attention. Contact a retina specialist or go to the emergency room right away if you notice any of the following changes.
- Sudden increase in floaters (spots or cobweb-like shapes drifting across your vision)
- Flashes of light in one or both eyes
- A curtain or shadow spreading over part of your vision
- Sudden loss of central vision in one eye
- New or rapidly worsening distortion of straight lines
These symptoms may indicate wet AMD activation, retinal detachment, or another serious condition. Prompt evaluation is critical to preserving your vision.
Frequently Asked Questions
Here are answers to questions our patients commonly ask about AMD, covering practical guidance, treatment decisions, and when to act.
AREDS2 supplements were studied in a specific population: people with intermediate AMD or advanced AMD in one eye. The clinical benefit has not been demonstrated for people with early AMD or no AMD at all. Standard multivitamins do not contain these nutrients at the doses shown to be beneficial, but taking the AREDS2 formula without confirmed intermediate or advanced AMD is not currently recommended. Always consult a retina specialist before starting these supplements.
For wet AMD, most patients require long-term, ongoing anti-VEGF injections to maintain results. Stopping treatment entirely often leads to recurrence of fluid and vessel leakage, with associated vision decline. The goal over time is to extend the interval between injections as much as possible while keeping the disease stable. Newer agents like Eylea HD and Vabysmo were developed specifically to allow longer intervals for appropriate patients, but your retina specialist will use OCT imaging and exam findings to determine the right schedule for you.
Yes, dry AMD can convert to wet AMD at any point, even after years of stable dry disease. This is one of the key reasons that regular monitoring and Amsler grid checks at home are so important. Any sudden change in distortion, new blind spots, or rapid vision changes in a person with known dry AMD should be evaluated by a retina specialist without delay, as prompt treatment of newly activated wet AMD can significantly protect remaining vision.
Having AMD in one eye does place the other eye at elevated risk. The degree of risk depends on the severity of disease in the affected eye and other individual factors. People with advanced AMD in one eye are generally the ones recommended to use AREDS2 supplements, precisely because of this concern about the fellow eye. Regular monitoring of both eyes is essential, even when one eye appears unaffected.
These are completely different treatments for different forms of AMD. Anti-VEGF injections target wet AMD by blocking the protein that causes abnormal blood vessel growth. Photobiomodulation with the Valeda Light Delivery System is a non-invasive light-based therapy authorized for dry (non-neovascular) AMD, aimed at supporting retinal cell function. It is not a substitute for anti-VEGF therapy in wet AMD. A retina specialist can explain which treatment or combination of approaches is most appropriate based on your diagnosis.
The Amsler grid is your best home monitoring tool, but it is most useful when used consistently and correctly, meaning testing each eye separately, at the same distance from the grid, and with any reading glasses you normally wear. Any change from your personal baseline, such as lines appearing more wavy or a spot becoming larger, warrants a call to your retina specialist rather than waiting for your next scheduled visit. Early identification of progression allows for faster treatment decisions.
Expert Macular Degeneration Care at Rhode Island Eye Institute
At Rhode Island Eye Institute, our retina specialists, Dr. Gaurav Gupta and Dr. Pranjal Thakuria, bring fellowship-level training and extensive experience to the diagnosis and treatment of macular degeneration at every stage. We use advanced imaging technology, offer the most current treatment options, and take time to help each patient understand their condition and their choices. If you have been diagnosed with AMD, have risk factors for the disease, or simply want expert guidance on protecting your long-term vision, we are here to help. Contact our team to schedule a consultation or a comprehensive dilated eye exam with one of our retina specialists.